Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

Sep 15, 2026
Sale
Shares
1,000
Price
$72.98
Total Value
$72.98K
Shares Held After
0
% of Holdings
100.0%

Ameresco, Inc. (AMRC)

Maltezos Louis P — Co-President
Sep 15, 2026
Sale
Shares
592
Price
$22.46
Total Value
$13.30K
Shares Held After
33,628
% of Holdings
1.7%

Rubrik, Inc. (RBRK)

Choudary Kiran Kumar — Chief Financial Officer
Sep 15, 2026
Sale
Shares
400
Price
$103.48
Total Value
$41.39K
Shares Held After
978,073
% of Holdings
0.0%

Rubrik, Inc. (RBRK)

Choudary Kiran Kumar — Chief Financial Officer
Sep 15, 2026
Sale
Shares
700
Price
$102.72
Total Value
$71.90K
Shares Held After
978,473
% of Holdings
0.1%

Rubrik, Inc. (RBRK)

Choudary Kiran Kumar — Chief Financial Officer
Sep 15, 2026
Sale
Shares
1,214
Price
$101.47
Total Value
$123.18K
Shares Held After
979,173
% of Holdings
0.1%

Rubrik, Inc. (RBRK)

Choudary Kiran Kumar — Chief Financial Officer
Sep 15, 2026
Sale
Shares
586
Price
$100.20
Total Value
$58.72K
Shares Held After
980,387
% of Holdings
0.1%

Rubrik, Inc. (RBRK)

Choudary Kiran Kumar — Chief Financial Officer
Sep 15, 2026
Sale
Shares
1,100
Price
$99.08
Total Value
$108.99K
Shares Held After
980,973
% of Holdings
0.1%

Travere Therapeutics, Inc. (TVTX)

Inrig Jula — EVP, Head of R&D&CMO
Sep 15, 2026
Sale
Shares
400
Price
$65.31
Total Value
$26.12K
Shares Held After
100,491
% of Holdings
0.4%

Travere Therapeutics, Inc. (TVTX)

Inrig Jula — EVP, Head of R&D&CMO
Sep 15, 2026
Sale
Shares
1,600
Price
$63.69
Total Value
$101.90K
Shares Held After
100,891
% of Holdings
1.6%

Travere Therapeutics, Inc. (TVTX)

Inrig Jula — EVP, Head of R&D&CMO
Sep 15, 2026
Sale
Shares
17,284
Price
$62.62
Total Value
$1.08M
Shares Held After
102,491
% of Holdings
14.4%

Travere Therapeutics, Inc. (TVTX)

Inrig Jula — EVP, Head of R&D&CMO
Sep 15, 2026
Sale
Shares
25,390
Price
$62.02
Total Value
$1.57M
Shares Held After
119,775
% of Holdings
17.5%

Travere Therapeutics, Inc. (TVTX)

Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Sep 15, 2026
Sale
Shares
300
Price
$63.66
Total Value
$19.10K
Shares Held After
42,353
% of Holdings
0.7%

Travere Therapeutics, Inc. (TVTX)

Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Sep 15, 2026
Sale
Shares
800
Price
$62.85
Total Value
$50.28K
Shares Held After
42,653
% of Holdings
1.8%

Travere Therapeutics, Inc. (TVTX)

Calvin Sandra — SVP, CHIEF ACCOUNTING OFFICER
Sep 15, 2026
Sale
Shares
4,275
Price
$62.13
Total Value
$265.63K
Shares Held After
43,453
% of Holdings
9.0%

Travere Therapeutics, Inc. (TVTX)

Cline Christopher R. — CHIEF FINANCIAL OFFICER
Sep 15, 2026
Sale
Shares
400
Price
$65.31
Total Value
$26.12K
Shares Held After
87,508
% of Holdings
0.5%

Travere Therapeutics, Inc. (TVTX)

Cline Christopher R. — CHIEF FINANCIAL OFFICER
Sep 15, 2026
Sale
Shares
1,900
Price
$63.69
Total Value
$121.00K
Shares Held After
87,908
% of Holdings
2.1%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Sep 15, 2026
Sale
Shares
300
Price
$65.31
Total Value
$19.59K
Shares Held After
105,389
% of Holdings
0.3%
Sep 15, 2026
Sale
Shares
270
Price
$65.31
Total Value
$17.63K
Shares Held After
432,886
% of Holdings
0.1%

Travere Therapeutics, Inc. (TVTX)

Cline Christopher R. — CHIEF FINANCIAL OFFICER
Sep 15, 2026
Sale
Shares
20,735
Price
$62.61
Total Value
$1.30M
Shares Held After
89,808
% of Holdings
18.8%
Sep 15, 2026
Sale
Shares
3,102
Price
$63.64
Total Value
$197.42K
Shares Held After
433,156
% of Holdings
0.7%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Sep 15, 2026
Sale
Shares
1,400
Price
$63.69
Total Value
$89.17K
Shares Held After
105,689
% of Holdings
1.3%
Sep 15, 2026
Sale
Shares
28,796
Price
$62.66
Total Value
$1.80M
Shares Held After
436,258
% of Holdings
6.2%

Travere Therapeutics, Inc. (TVTX)

Cline Christopher R. — CHIEF FINANCIAL OFFICER
Sep 15, 2026
Sale
Shares
27,473
Price
$62.00
Total Value
$1.70M
Shares Held After
110,543
% of Holdings
19.9%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Sep 15, 2026
Sale
Shares
13,874
Price
$62.63
Total Value
$868.96K
Shares Held After
107,089
% of Holdings
11.5%
Sep 15, 2026
Sale
Shares
63,498
Price
$61.99
Total Value
$3.94M
Shares Held After
465,054
% of Holdings
12.0%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Sep 15, 2026
Sale
Shares
21,926
Price
$62.03
Total Value
$1.36M
Shares Held After
120,963
% of Holdings
15.3%

Travere Therapeutics, Inc. (TVTX)

ROTE WILLIAM E. — Chief Research Officer
Sep 15, 2026
Sale
Shares
270
Price
$65.31
Total Value
$17.63K
Shares Held After
98,197
% of Holdings
0.3%

Travere Therapeutics, Inc. (TVTX)

ROTE WILLIAM E. — Chief Research Officer
Sep 15, 2026
Sale
Shares
3,000
Price
$63.65
Total Value
$190.95K
Shares Held After
98,467
% of Holdings
3.0%

Travere Therapeutics, Inc. (TVTX)

ROTE WILLIAM E. — Chief Research Officer
Sep 15, 2026
Sale
Shares
29,021
Price
$62.66
Total Value
$1.82M
Shares Held After
101,467
% of Holdings
22.2%

Travere Therapeutics, Inc. (TVTX)

ROTE WILLIAM E. — Chief Research Officer
Sep 15, 2026
Sale
Shares
63,907
Price
$61.99
Total Value
$3.96M
Shares Held After
130,488
% of Holdings
32.9%

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Sep 15, 2026
Sale
Shares
1,431
Price
$65.31
Total Value
$93.46K
Shares Held After
117,066
% of Holdings
1.2%

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Sep 15, 2026
Sale
Shares
1,400
Price
$63.65
Total Value
$89.11K
Shares Held After
118,497
% of Holdings
1.2%

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Sep 15, 2026
Sale
Shares
27,421
Price
$62.59
Total Value
$1.72M
Shares Held After
119,897
% of Holdings
18.6%

Travere Therapeutics, Inc. (TVTX)

Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Sep 15, 2026
Sale
Shares
71,938
Price
$62.05
Total Value
$4.46M
Shares Held After
147,318
% of Holdings
32.8%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Sep 15, 2026
Sale
Shares
6,000
Price
$350.07
Total Value
$2.10M
Shares Held After
224,464
% of Holdings
2.6%
Sep 15, 2026
Sale
Shares
150,000
Price
$7.74
Total Value
$1.16M
Shares Held After
11,712,202
% of Holdings
1.3%

Ceribell, Inc. (CBLL)

Blumberg Scott — Chief Financial Officer
Sep 15, 2026
Sale
Shares
846
Price
$25.00
Total Value
$21.15K
Shares Held After
146,600
% of Holdings
0.6%

Ceribell, Inc. (CBLL)

Chao Xingjuan — Director
Sep 15, 2026
Sale
Shares
20,846
Price
$25.03
Total Value
$521.78K
Shares Held After
746,345
% of Holdings
2.7%
Sep 15, 2026
Sale
Shares
510
Price
$176.11
Total Value
$89.81K
Shares Held After
1,063,095
% of Holdings
0.0%
Sep 15, 2026
Sale
Shares
1,843
Price
$175.17
Total Value
$322.84K
Shares Held After
1,063,605
% of Holdings
0.2%
Sep 15, 2026
Sale
Shares
2,129
Price
$174.25
Total Value
$370.99K
Shares Held After
1,065,448
% of Holdings
0.2%
Sep 15, 2026
Sale
Shares
2,319
Price
$173.05
Total Value
$401.31K
Shares Held After
1,067,577
% of Holdings
0.2%
Sep 15, 2026
Sale
Shares
3,990
Price
$172.24
Total Value
$687.22K
Shares Held After
1,069,896
% of Holdings
0.4%
Sep 15, 2026
Sale
Shares
3,901
Price
$171.09
Total Value
$667.41K
Shares Held After
1,073,886
% of Holdings
0.4%
Sep 15, 2026
Sale
Shares
1,308
Price
$170.26
Total Value
$222.70K
Shares Held After
1,077,787
% of Holdings
0.1%

Paysign, Inc. (PAYS)

Herman Joan M — Director
Sep 15, 2026
Sale
Shares
21,004
Price
$12.38
Total Value
$260.07K
Shares Held After
648,321
% of Holdings
3.1%
Sep 15, 2026
Sale
Shares
420
Price
$48.89
Total Value
$20.53K
Shares Held After
175,653
% of Holdings
0.2%
Sep 15, 2026
Sale
Shares
3,380
Price
$48.17
Total Value
$162.81K
Shares Held After
176,073
% of Holdings
1.9%
Sep 15, 2026
Sale
Shares
2,700
Price
$47.24
Total Value
$127.55K
Shares Held After
179,453
% of Holdings
1.5%
Sep 15, 2026
Sale
Shares
1,000
Price
$48.50
Total Value
$48.50K
Shares Held After
61,200
% of Holdings
1.6%
Version: v26.9.1